)
Alkem Laboratories (ALKEM) investor relations material
Alkem Laboratories Investor Day Presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Strategic direction and market opportunity
Expansion into MedTech aligns with sector growth, targeting a $680B global market projected to reach $870B by 2030, with India’s market expected to nearly double by 2030.
Focus on high-growth, high-margin segments: orthopedics (knee and hip implants) and cardiovascular devices, leveraging innovation and cost-competitive manufacturing.
Government policies and rising insurance penetration in India support sector growth and localization, reducing import dependency.
Emphasis on recurring revenue through strong customer loyalty and a consolidated industry structure.
Business development and execution
Hybrid approach in orthopedics: organic growth via tech transfer and asset acquisition, with state-of-the-art manufacturing and a five-year vision to reach 250,000+ implants and 10% market share in India.
Cardiovascular entry driven by acquisition and portfolio expansion, targeting structural heart and closure devices, with a focus on global market access.
Acquisition of a 51-55% stake in Occlutech Holding AG for €180.7M, funded by internal accruals, expected to close by June 2026.
Occlutech brings a strong global presence, robust R&D, and a complete portfolio of minimally invasive cardiac devices, with 200,000+ implants sold and 14% CAGR (2021-25).
Financial guidance and future outlook
Acquisition expected to enhance global reach, operational excellence, and product innovation, leveraging synergies for value creation.
High EBITDA margins anticipated for scaled Indian players operating globally, with continuous management initiatives to optimize the business model.
Regulatory approvals for new products (knee, hip, and cardiac devices) targeted between Q4 FY27 and Q4 FY28, supporting international expansion.
Commitment to building a comprehensive, high-quality MedTech portfolio and a strong ecosystem through vertical integration and skill development.
Next Alkem Laboratories earnings date
Next Alkem Laboratories earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage